Functional Medicine | Get Healthy Now, Naturally | Alternative Health Information Functional Medicine | Get Healthy Now, Naturally | Alternative Health Information Functional Medicine | Get Healthy Now, Naturally | Alternative Health Information Functional Medicine | Get Healthy Now, Naturally | Alternative Health Information Your Medical Detective

Jefferson Scientists Find Zinc May Help Prevent Esophageal, Oral Cancers

Print Page

Cancer researchers at Jefferson Medical College and the Kimmel Cancer Center at Thomas Jefferson University in Philadelphia have found that zinc treatment may help prevent esophageal and oral cancers in those individuals at high risk. Related News Stories

Gene Therapy Success In The Laboratory Buoys Hope For Cancer Treatment And Prevention; Can Simply Swallowing A Gene Actually Treat And Prevent Cancer? (March 14, 2001) -- While the scientific jury is still out on that question, cancer geneticists and neuroscientists at Jefferson Medical College have seen stunning results in a gene therapy experiment in laboratory ... > full story

Jefferson Scientists Find Radiation And Blood Vessel Inhibitor More Effective Against Brain Tumors (November 25, 2003) -- Combining radiation with an agent that blocks VEGF, a protein that promotes the development of blood vessels and the growth of cancerous tumors -- a process known as angiogenesis -- may be more ... > full story

Zinc Deficiency Linked To Increased Risk Of Less--Common Form Of Esophageal Cancer (February 23, 2005) -- Researchers at the National Cancer Institute (NCI), part of the National Institutes of Health, have found that zinc deficiency in humans is associated with an increased risk of developing esophageal ... > full story

Giving Smaller Doses Of Chemotherapy More Frequently May Attack Tumor Blood Supply (March 28, 2001) -- Radiation oncologists at Thomas Jefferson University Hospital are rethinking how to give chemotherapy, taking advantage of its unique properties. They are giving chemotherapy more frequently than ... > full story

> more related stories Related section: Health & Medicine

Oral and esophageal cancers are associated with nutritional zinc deficiency, and a rise in the expression of the enzyme COX-2 is connected with these cancers.

Louise Fong, Ph.D., assistant professor of microbiology and immunology at Jefferson Medical College of Thomas Jefferson University, and her co-workers have found that zinc given orally to zinc-deficient rats reverses the development of precancerous conditions in the esophagus and tongue and reverses the high expression of COX-2 there as well.

These findings suggest that zinc supplements may prevent the development of esophageal or oral cancers, particularly in developing countries where zinc deficiency is a problem. The researchers reported their findings January 5, 2005 in the Journal of the National Cancer Institute. Zinc in the diet comes mostly from red meat and seafood. Whereas up to 10 percent of Americans have a zinc-deficient diet, as many as 2 billion individuals in developing countries are zinc-deficient. Epidemiological evidence show the incidence of esophageal and oral cancers is rising in recent years. As many as 13,000 Americans die from esophageal cancer each year.

Dr. Fong has been studying zinc deficiency and its connection to esophageal cancer for some 20 years, and has developed animal models of zinc deficiency and cancer susceptibility. Zinc deficiency, she says, increases cell proliferation in the esophagus and in the tongue, making both areas susceptible to carcinogens and increasing the risk of cancer development. In 2002, Dr. Fong reported that rats given a carcinogen while on a zinc-deficient diet developed esophageal cancer. Giving zinc prevented the cancer.

Dr. Fong wanted to know if zinc could regulate COX-2 expression in esophageal and tongue cancers. She and her co-workers compared COX-2 protein and gene expression in esophageal and tongue tissue in normal rats, zinc-deficient rats and in zinc-deficient rats that had received zinc. They found COX-2 expression was increased 10-to-15-fold in zinc-deficient rats. Cellular proliferation was similarly increased. After giving zinc to the deficient rats, COX-2 expression was markedly reduced and the precancerous cellular proliferation was reversed. The rats lacking dietary zinc were also treated with COX-2 inhibitors, celecoxib (Celebrex) and indomethacin. They found that the rats treated with the COX-2 inhibitors had a reduction in both COX-2 and cellular proliferation in the esophagus.

"Zinc treatment restores many systems affected by the lack of zinc," Dr. Fong notes. "Zinc deficiency upregulates COX-2. Zinc replenishment restores it to near normal levels." In the future, she and her co-workers would like to determine whether zinc in combination with low amounts of celecoxib can prevent upper aerodigestive tract cancers, including esophageal and oral cancers.

Editor's Note: The original news release can be found here.